Harrington Discovery Institute England Ohio
10.09.2025 - 21:32:57Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025
Lord Cameron, Chair of the OHC Advisory Council, said: "Of the causes I have advocated, this one is personal. The Oxford-Harrington Rare Disease Centre brings together the very best of academia, life sciences, philanthropy, and industry to deliver hope for millions worldwide living with rare diseases. I was honoured to represent the OHC at Exchange 2025, to discuss our work to help the many millions of families whose lives are affected by these devastating conditions. Progress at the scale we need will only happen if philanthropy and investment step forward boldly. By convening leading institutions, funders, and innovators, we hope to accelerate the development of treatments and create real change for patients and their loved ones."
Andy Saperstein, Co-President of Morgan Stanley, said: "We were honored to welcome Lord Cameron to Exchange 2025 for a truly inspiring conversation. His leadership at the Oxford-Harrington Rare Disease Centre highlights how collaboration across science, philanthropy, and investment can transform the future for millions of patients worldwide. At Morgan Stanley, we believe in the power of courageous ideas, as illustrated by our partnership with Harrington Discovery Institute, to drive new cures, and this dialogue shined a light on the role we can all play in advancing solutions for rare diseases."
The Morgan Stanley Exchange brings together leaders in philanthropy, healthcare, and innovation to explore bold ideas for addressing global challenges. Lord Cameron's participation underscored the importance of investment, partnership, and the role of philanthropy in bridging funding gaps to deliver new treatments for rare diseases.
Photo - https://mma.prnewswire.com/media/2770472/Harrington_Discovery_Institute_image.jpg
View original content:
